Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06975423 · ClinicalTrials.gov registry record · NA

Walking Sensation Study

A NA study of Aging and Sensory Deficit, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06975423 is a NA study of Aging and Sensory Deficit that is actively recruiting participants, run by University of Florida. The registered enrollment target is 30 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06975423, a NA study of Aging and Sensory Deficit, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins will enhance the automaticity and reduce cognitive demand of walking in older adults with foot sensory impairments, as measured by reduced prefrontal activity, decreased dual-task costs, and lower gait variability.

Conditions Studied

Interventions

  • DEVICE Active lower-limb neuroprosthesis
  • DEVICE Inactive lower-limb neuroprosthesis

Study Locations (1)

Florida

  • Clinical and Translational Research Building - Gainesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-09-08
Est. Completion 2027-03-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT06975423

The ClinicalTrials.gov registry entry for NCT06975423 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Active lower-limb neuroprosthesis is the first listed.

NCT06975423 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06975423 about?

NCT06975423 is a clinical study titled "Walking Sensation Study". The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins wi...

What is the current status of trial NCT06975423?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-09-08. Estimated completion is 2027-03-31.

What conditions does trial NCT06975423 study?

This clinical trial studies the following conditions: Aging, Sensory Deficit.

What interventions are being tested in trial NCT06975423?

The interventions under investigation include: Active lower-limb neuroprosthesis (DEVICE), Inactive lower-limb neuroprosthesis (DEVICE).

Who is sponsoring clinical trial NCT06975423?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06975423 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.